The application of somatostatin showed a dramatic decrease of the incidence of bladder cancer due to the carcinogenic effect of nitrosamine in rats, suggesting a protective effect possibly by supporting apoptosis of dysplastic cells at risk malignification [21]. The gene discussed is SST; the disease is urinary bladder cancer.